Paige Bischoff, Senior VP, Public Affairs, Alliance for Regenerative Medicine
Paige Bischoff, Senior VP, Alliance for Regenerative Medicine (ARM), Washington, DC, talks on her role at ARM and the effective communication strategy recently implemented at the organization. This interview took place during the 2020 Meeting on the Mesa congress.
Видео Paige Bischoff, Senior VP, Public Affairs, Alliance for Regenerative Medicine канала VJRegenMed
Видео Paige Bischoff, Senior VP, Public Affairs, Alliance for Regenerative Medicine канала VJRegenMed
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![CAR-T trials to watch in China](https://i.ytimg.com/vi/g-dN3U2Ht9U/default.jpg)
![Exploring the potential role of CD7-targeting CAR-T cells in T-ALL](https://i.ytimg.com/vi/YlMw43TyJHQ/default.jpg)
![Current developments in cell therapies for solid tumors](https://i.ytimg.com/vi/QITTCJh9Fvo/default.jpg)
![Tabelecleucel in EBV-associated PTLD](https://i.ytimg.com/vi/8JcXIlfI-q8/default.jpg)
![Challenges in decentralized manufacturing systems](https://i.ytimg.com/vi/T3PBj8gYXH8/default.jpg)
![Infectious complications after CAR T-cell therapy](https://i.ytimg.com/vi/gGSKVddv7dE/default.jpg)
![PiggyBac Transposon-generated CAR T-cells in solid tumors](https://i.ytimg.com/vi/UZ1FNxol_EM/default.jpg)
![Nerve regeneration with polyhydroxyalkanoate-based conduits](https://i.ytimg.com/vi/5Iv5tFCWmt0/default.jpg)
![LUMEVOQ gene therapy for LHON](https://i.ytimg.com/vi/ZICV7g0pPno/default.jpg)
![Harnessing lipid-specific TCRs to target CD1c-expressing leukemia](https://i.ytimg.com/vi/WH1CmN9pOtw/default.jpg)
![EV-based therapies for myocardial infarction](https://i.ytimg.com/vi/xmCwbtvybxo/default.jpg)
![Plasmacytoid dendritic cell-based cancer vaccines](https://i.ytimg.com/vi/iOzC5GkNcxQ/default.jpg)
![Limitations in the application of stem cell therapies](https://i.ytimg.com/vi/qy4b-gDOtTI/default.jpg)
![The changing landscape of hospital-based cell and gene therapy manufacturing](https://i.ytimg.com/vi/ewPHBOWF2ME/default.jpg)
![Increasing manufacturing capabilities for gene therapies](https://i.ytimg.com/vi/cdzjk2TvcIQ/default.jpg)
![Targeting solid tumors: SPEAR T-cells & HLA-independent TCRs](https://i.ytimg.com/vi/KN-qODpT6Bo/default.jpg)
![Developing gene therapies for GJB2 gene related hearing loss](https://i.ytimg.com/vi/ZkRtcwnfNvs/default.jpg)
![Progression of CAR-T trials in China](https://i.ytimg.com/vi/__VdZLVS0bA/default.jpg)
![Challenges in developing cord blood- and cord tissue-based therapies](https://i.ytimg.com/vi/wxLGqo5h99U/default.jpg)
![Spatially patterned scaffolds in vascular regeneration](https://i.ytimg.com/vi/2dL0lnxZWOc/default.jpg)